Our in vitro results suggest that treatment with high doses of estrogen and progesterone promotes the expression of host antiviral factors Secretory leukocyte protease inhibitor (SLPI) and Serpin family C member 1 (SERPIN C1), among others produced in response to HIV-1 infection. Here, SLPI is linked to HIV-1 infection.